Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 549 of 6351
-
Radiation plus Chemo-Immunotherapy shows promise in High-Risk breast cancer trial
Disease control Not yet recruitingThis study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy and safety of combining radiotherapy, chemotherapy, and immunotherapy in the neoadjuvant treatment of high-risk HR+/HER2- breast cancer patients. The study plans to enroll treatme…
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Surgery-free breast cancer treatment tested in new trial
Disease control Not yet recruitingThis study aims to evaluate the 5-year invasive ipsilateral breast cancer incidence rate in patients with hormone-receptor positive, HER-2 negative atypical ductal hyperplasia or in-situ carcimona who omitted surgery and received endocrine therapy.
Sponsor: Jeong Eon Lee • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New targeted drug combo aims to shrink breast tumors before surgery
Disease control Not yet recruitingThis is a prospective, randomized, multi-cohort, Phase II clinical trial. The study plans to enroll 120 patients with early-stage or locally advanced, HR-positive, HER2-low breast cancer. The primary objective is to evaluate the efficacy and safety of SHR-A1811 with or without en…
Phase 2 • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Invisible hearing: new implant hides under the skin
Disease control OngoingThis clinical study examines the performance of an investigational totally implantable cochlear implant (TICI) system. The system includes an implantable microphone under the skin to detect speech and sound from the environment allowing the option to hear without the need of an e…
Sponsor: Cochlear • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Real-time DNA test during brain surgery could help remove more cancer
Diagnosis Not yet recruitingThis is a single-site, single-arm, prospective, interventional cohort study using intraoperative ultra-rapid droplet digital polymerase chain reaction (UR- ddPCR) to assess residual IDH1-mutant tumor at the end of surgical resection and, if positive, guide additional resection in…
Sponsor: NYU Langone Health • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New device seals Stroke-Causing heart pouch during bypass surgery
Disease control Recruiting nowAtrial fibrillation is a common heart rhythm disorder that increases the risk of stroke. In patients with atrial fibrillation, blood clots most often form in a small structure of the heart called the left atrial appendage. If a blood clot travels from the heart to the brain, it c…
Sponsor: Institute of Cardiovascular Diseases, Vojvodina • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug targets Hard-to-Treat cancers with MET gene change
Disease control Recruiting nowCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity of telisotuzumab adizutecan. Telisotuzumab adizutecan is an investigational drug being developed f…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New drug combo targets rare lung cancer in early trial
Disease control Not yet recruitingThis single-arm, open-label, Phase II study assesses first-line QL1706 (iparomlimab and tuvonralimab, an anti-PD-1/CTLA-4 bispecific antibody) combined with platinum-based chemotherapy to treat patients with treatment-naïve, locally advanced or metastatic, SMARCA4-deficient non-s…
Phase 2 • Sponsor: Zhijie Wang • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug aims to shield heart and kidneys from major events
Disease control Recruiting nowThe purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug duo takes on tough breast cancer
Disease control Not yet recruitingThis study is aimed to evaluate the efficacy and safety of Sacituzumab Tirumotecan combined with Toripalimab for first-line treatment of PD-L1 positive unresectable Locally Advanced/metastatic triple negative breast cancer (a/mTNBC).
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug may offer better control for rare Muscle-Weakening disease before surgery
Disease control Not yet recruitingThis study is a prospective, multi-center, randomized controlled study to evaluate the efficacy and safety of efgartigimod (EFG) and intravenous immunoglobulin (IVIG) in the perioperative application for acetylcholine receptor (AChR) antibody-positive thymoma patients with myasth…
Phase 3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
AI eye test could spot Alzheimer's early
Diagnosis Not yet recruitingThe purpose of this study is to test the use of a screening tool to detect changes in the eye that are associated with Alzheimer's disease in adult participants with memory issues. For each participant, the study will last up to one month and requires one visit to the research si…
Sponsor: Eli Lilly and Company • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Can a double dose stop Post-Procedure pancreatitis?
Prevention Not yet recruitingOur aim is to compare the efficacy of 100 mg versus 200 mg rectal indometacin in preventing post-ERCP pancreatitis (PEP) among high-risk patients without no pancreatic stenting. The 100 mg versus 200 mg indometacin trial is a multicentre, single-blind, randomized controlled study…
Phase 4 • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Could laughter be the key to a calmer, clearer pregnancy?
Symptom relief By invitation onlyPregnancy is a physiological process during which a number of biological changes occur in a woman's body. This period represents an important turning point in the lives of women, whose reproductive capacity ensures the continuation of generations. While some women perceive pregna…
Sponsor: Agri Ibrahim Cecen University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New hope for liver cancer patients: 4-drug combo targets untreatable tumors
Disease control Not yet recruitingThis study is a single arm, single center, open label clinical trial. Recruit 34 subjects who meet the inclusion criteria and receive hepatic artery chemoembolization (TACE) and stereotactic body radiotherapy (SBRT) combined with immune checkpoint inhibitors and donafenib treatme…
Phase 2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Immunotherapy plus chemo shows promise for pancreatic cancer before surgery
Disease control Not yet recruitingClinical Study on the Safety and Efficacy of the efficacy and safety of Adebrelimab combined with chemotherapy for neoadjuvant treatment of resectable pancreatic cancer
Phase 2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo aims to tame advanced cervical cancer with fewer side effects
Disease control Not yet recruitingThis study is a prospective, randomized, parallel investigation aimed at evaluating different doses of famitinib malate (20mg, 15mg, or 10mg, once daily, respectively) by analyzing the pharmacokinetics, efficacy, safety, and tolerability of famitinib malate combined with camreliz…
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Engineered immune cells take aim at tough leukemia
Disease control Recruiting nowThis is an open-label, single-arm clinical study designed to evaluate the efficacy and safety of IL-5 CAR-T cell therapy in the treatment of patients with CD125-positive eosinophilic leukemia.
Phase 1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could surgery after hormone therapy beat advanced prostate cancer?
Disease control Not yet recruitingThis is a prospective, randomized, open-label, phase II multicenter clinical trial evaluating the efficacy and safety of radical prostatectomy in patients with high-volume metastatic hormone-sensitive prostate cancer (mHSPC) who achieve good response after systemic therapy with a…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a common drug prevent brain damage after a stroke?
Disease control Not yet recruitingThe investigators propose to conduct a multicenter randomized trial to test whether cilostazol reduces the incidence of delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH) and improves patients' neurological prognosis, while assessing its safety.
Phase 3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC